Literature DB >> 32052591

Electromagnetic navigation bronchoscopy for lung nodule evaluation. Patient selection, diagnostic variables and safety.

Frank D Andersen1, Kristine B Degn2, Torben Riis Rasmussen2.   

Abstract

BACKGROUND: Electromagnetic navigation bronchoscopy (ENB) is a relatively new technique to diagnose pulmonary lesions in patients with reduced lung function. Several parameters have been shown to affect diagnostic yield including patient selection. We performed a prospective registration of data on one hundred patients who consecutively underwent electromagnetic navigation bronchoscopy. Selection criteria, patient characteristics, lesion size, distance to pleura, location of the lesion and presence of bronchus sign on computed tomography were registered.
METHODS: Navigation was performed using the superDimension hardware and software system. Patients were referred to ENB from a multidisciplinary team conference. We did not use fluoroscopy, endobronchial ultrasound equipment, rapid onsite evaluation or general anesthesia during the procedure. All patients in whom no malignant diagnose was found were subsequently followed for two years in order to verify a benign nature of the pulmonary lesion.
RESULTS: One hundred and nine ENB procedures were performed between September 2009 and November 2014. Overall diagnostic yield was 68%. Twenty seven of 49 malignant tumors were found by ENB leading to a sensitivity for malignancy of 55%. The sensitivity for malignancy was significantly higher for lesions in the upper and middle lobes compared to the lower lobes (P = 0.01). Lesions size, distance to pleura and presence of bronchus sign did not affect sensitivity.
CONCLUSION: ENB is a safe diagnostic procedure in an everyday setting with an acceptable diagnostic yield even without addition of supportive diagnostic methods and offers a possibility to diagnose pulmonary nodules in patients for whom other diagnostic procedures are too hazardous or have proven unsuccessful.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  bronchoscopy; electromagnetic; lung cancer; navigation; pulmonary nodule

Year:  2020        PMID: 32052591     DOI: 10.1111/crj.13168

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  4 in total

1.  The Impact of Biopsy Tool Choice and Rapid On-Site Evaluation on Diagnostic Accuracy for Malignant Lesions in the Prospective: Multicenter NAVIGATE Study.

Authors:  Thomas R Gildea; Erik E Folch; Sandeep J Khandhar; Michael A Pritchett; Gregory P LeMense; Philip A Linden; Douglas A Arenberg; Otis B Rickman; Amit K Mahajan; Jaspal Singh; Joseph Cicenia; Atul C Mehta; Haiying Lin; Jennifer S Mattingley
Journal:  J Bronchology Interv Pulmonol       Date:  2021-07-01

2.  Clinical value of an electromagnetic navigation system for CT-guided percutaneous lung biopsy of peripheral lung lesions.

Authors:  Yao Zhang; Haozhe Huang; Shuhui Cao; Jiajun Teng; Yue Wang; Xuxinyi Ling; Yan Zhou; Jianlin Xu; Wentao Li; Hua Zhong
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

Review 3.  [Application and Progress of Electromagnetic Navigation Bronchoscopy in Department of Thoracic Surgery].

Authors:  Chao Guo; Xiayao Diao; Cheng Huang; Yeye Chen; Ye Zhang; Shanqing Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-02-20

4.  Evaluation of the synergistic impact of needle and forceps biopsy with electromagnetic navigation bronchoscopy: the CONFIDENT-ENB trial design.

Authors:  Yeon Wook Kim; Hyung-Jun Kim; Sung Hyun Yoon; Kyung Hee Lee; Young Mi Park; So Yeon Ahn; Myung Jin Song; Byoung Soo Kwon; Sung Yoon Lim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jae Ho Lee; Choon-Taek Lee
Journal:  BMC Pulm Med       Date:  2022-08-19       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.